SPDR Solactive Hong Kong ETF
ZHOK
ZHOK was delisted on the 17th of March, 2021.
6 hedge funds and large institutions have $13.6M invested in SPDR Solactive Hong Kong ETF in 2020 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 0 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
50% more funds holding
Funds holding: 4 → 6 (+2)
16% more capital invested
Capital invested by funds: $11.7M → $13.6M (+$1.89M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$2.47M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$347K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$21.7K |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
+$3.47K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MAM
Marotta Asset Management
Charlottesville,
Virginia
|
-$2.55M |
ZHOK Hedge Fund Activity: Q4 2020 in Review
6 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in SPDR Solactive Hong Kong ETF (ZHOK) for Q4 2020, worth a combined $13.6M — up 16% from $11.7M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new ZHOK positions and 0 closed out — a net gain of 2 holders — while 2 added to existing stakes and 1 trimmed.
The largest buyer was Jane Street, adding an estimated $2.47M. The largest seller was Marotta Asset Management, cutting an estimated $2.55M.
- 6 institutional investors held SPDR Solactive Hong Kong ETF (ZHOK) as of Q4 2020, up from 4 in Q3 2020.
- Funds reported $13.6M of SPDR Solactive Hong Kong ETF stock for Q4 2020, up 16% quarter-over-quarter.
- 2 funds opened new SPDR Solactive Hong Kong ETF positions in Q4 2020 and 0 closed out, a net change of +2 holders.
- The largest SPDR Solactive Hong Kong ETF buyer in Q4 2020 was Jane Street, an estimated $2.47M added.
- The largest SPDR Solactive Hong Kong ETF seller in Q4 2020 was Marotta Asset Management, an estimated $2.55M sold.
Based on aggregated 13F filings for Q4 2020.